Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Bre

Project: Research project

Project Details

Description

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk
StatusFinished
Effective start/end date1/1/155/31/17

Funding

  • THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
  • NATIONAL INSTITUTES OF HEALTH (NIH)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.